V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240012812 | 240009020 | 1.74 | 55.1 | Disease modification (D) | 2014-05-26 | 2014-06-18 | Triple / Double Intrathecal Therapy | N | N | 240019885 | PEMBROLIZUMAB |
| 240012813 | 240009020 | 1.74 | 79.8 | Adjuvant (A) | 2015-11-24 | 2015-12-30 | AML16 DA 3+10 | N | N | 240019885 | ATG + BUSULFAN + FLUDARABINE |
| 240012814 | 240009021 | 1.7 | 54.4 | Curative (C) | 2015-05-28 | 2015-05-28 | Escalated BEACOPP | N | N | 240021157 | ETOPOSIDE |
| 240012815 | 240009022 | 1.66 | 47 | Curative (C) | 2018-07-15 | 2018-10-26 | VEDex | 02 | N | 240021536 | CYTARABINE INTRATHECAL |
| 240012816 | 240009023 | null | 68 | Palliative (P) | 2017-07-10 | 2017-07-11 | FCR IV - Cycle 2 onwards | N | N | 240021819 | OXALIPLATIN + MDG |
| 240012817 | 240012822 | 1.72 | 113 | Disease modification (D) | 2016-05-14 | 2016-07-21 | PEMBROLIZUMAB | Y | null | 240022190 | IXAZOMIB + LENALIDOMIDE |
| 240012818 | 240012823 | 1.6 | null | Not known (9) | 2016-07-13 | 2016-08-18 | DA-EPOCH-R | N | N | 240022466 | CISPLATIN + FLUOROURACIL |
| 240012819 | 240009028 | 1.76 | null | Palliative (P) | 2015-04-11 | 2015-04-11 | Cytarabine HD + Methotrexate HD | N | N | 240023084 | Y-90 |
| 240012820 | 240009029 | 1.62 | 64.55 | Palliative (P) | 2015-12-12 | 2015-12-12 | R GDP | 2 | N | 240023588 | MABCUTE TRIAL |
| 240012821 | 240009030 | 1.66 | 70.8 | Curative (C) | 2019-06-17 | 2019-06-17 | IVAC | N | N | 240023588 | CAPECITABINE |
| 240012822 | 240009031 | 1.78 | 95.4 | Disease modification (D) | 2018-03-05 | 2018-03-09 | Carboplatin + Pemetrexed | N | N | 240025395 | BEACOPP |
| 240012823 | 240009032 | 1.66 | 84 | Palliative (P) | 2015-09-21 | 2015-09-21 | CARMUSTINE + THIOTEPA | 2 | N | 240025395 | CYTARABINE HIGH DOSE |
| 240012824 | 240009033 | null | 58 | Palliative (P) | null | 2014-09-29 | Carboplatin + Pemetrexed | N | N | 240030474 | CARBOPLATIN + RT |
| 240012825 | 240009034 | 1.66 | null | null | 2013-12-17 | 2014-01-30 | DOXORUBICIN | N | null | 240030474 | CARBOPLATIN + RT |
| 240012826 | 240009034 | 1.84 | 50 | Palliative (P) | 2019-08-07 | 2019-08-07 | Gemcitabine + Oxaliplatin | N | N | 240030474 | ESHAP |
| 240012827 | 240012827 | 1.73 | 50.4 | Curative (C) | 2017-11-07 | 2017-11-07 | UKALL14- Ph 2 Induction | N | N | 240015030 | ESHAP |
| 240012828 | 240005495 | 1.75 | null | Adjuvant (A) | 2017-07-07 | 2017-07-12 | Rituximab (INTRAVENOUS Maintenance) | 2 | N | 240000015 | RITUXIMAB |
| 240012829 | 240011016 | null | 94.5 | Disease modification (D) | 2014-06-30 | 2015-06-02 | Rituximab | N | N | 240000030 | RITUXIMAB |
| 240012830 | 240011018 | null | 55 | Palliative (P) | null | 2018-03-03 | Rituximab | null | null | 240000035 | RITUXIMAB |
| 240012831 | 240005500 | null | 81.2 | Disease modification (D) | 2015-08-21 | 2016-01-13 | Rituximab (SUBCUTANEOUS Maintenance) | N | null | 240000042 | RITUXIMAB |
| 240012832 | 240005502 | 1.79 | 69 | Curative (C) | 2018-08-23 | 2018-09-08 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 240000043 | RITUXIMAB |
| 240012833 | 240005505 | 1.76 | null | Adjuvant (A) | 2016-06-28 | 2016-07-13 | Rituximab | N | N | 240000077 | RITUXIMAB |
| 240012834 | 240005506 | null | 72 | null | 2014-01-19 | 2014-01-22 | Rituximab | 2 | null | 240000092 | RITUXIMAB |
| 240012835 | 240005511 | 0 | 50 | Palliative (P) | 2017-02-19 | 2017-02-24 | Rituximab | 02 | N | 240000133 | RITUXIMAB |
| 240012836 | 240005513 | 1.68 | null | Adjuvant (A) | 2016-11-22 | 2016-12-09 | Rituximab | N | N | 240000161 | RITUXIMAB |
| 240012838 | 240005517 | 1.75 | null | Curative (C) | 2017-08-16 | 2018-02-21 | Rituximab | 02 | null | 240000198 | RITUXIMAB |
| 240012839 | 240005521 | null | 58 | Palliative (P) | 2015-12-18 | 2016-06-27 | Rituximab (Maintenance) | N | null | 240000246 | RITUXIMAB |
| 240012840 | 240005526 | 1.75 | 69 | null | 2014-10-27 | 2014-11-09 | Rituximab | 02 | N | 240000281 | RITUXIMAB |
| 240012841 | 240005528 | 1.73 | 90.6 | Disease modification (D) | 2014-08-15 | 2015-03-03 | Rituximab | N | N | 240000291 | RITUXIMAB |
| 240012842 | 240011029 | 1.63 | 54.45 | Palliative (P) | 2017-10-14 | 2017-10-16 | Rituximab | N | N | 240000300 | RITUXIMAB |
| 240012843 | 240005535 | 1.65 | 100.4 | Disease modification (D) | 2016-02-15 | 2016-02-15 | Rituximab | 02 | N | 240000359 | RITUXIMAB |
| 240012844 | 240005539 | 1.55 | 68.45 | Disease modification (D) | 2015-12-30 | 2015-12-30 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 240000406 | RITUXIMAB |
| 240012845 | 240005540 | null | null | Adjuvant (A) | 2016-07-20 | 2016-07-28 | Rituximab | 2 | null | 240000439 | RITUXIMAB |
| 240012846 | 240011034 | 1.71 | 73 | Curative (C) | 2014-03-16 | 2015-02-11 | Rituximab | N | N | 240000481 | RITUXIMAB |
| 240012847 | 240005545 | null | 106 | null | 2015-02-07 | 2017-09-21 | Rituximab | N | N | 240000515 | RITUXIMAB |
| 240012848 | 240005546 | 0 | 84.3 | Curative (C) | 2015-03-20 | 2015-04-03 | Rituximab | N | N | 240000529 | RITUXIMAB |
| 240012849 | 240005548 | 1.66 | 114 | Disease modification (D) | null | 2018-06-19 | Rituximab | N | N | 240000531 | RITUXIMAB |
| 240012850 | 240005551 | 1.8 | 89.3 | Not known (9) | 2013-09-30 | 2013-10-04 | Rituximab | 2 | N | 240000580 | RITUXIMAB |
| 240012851 | 240005555 | null | 74 | Disease modification (D) | 2016-06-17 | 2016-07-07 | Rituximab | 2 | N | 240000605 | RITUXIMAB |
| 240012852 | 240005560 | 1.62 | 60.7 | Disease modification (D) | 2015-11-30 | 2015-12-21 | Rituximab | 02 | N | 240000651 | RITUXIMAB |
| 240012853 | 240005561 | 1.68 | 64 | Not known (9) | 2016-04-18 | 2016-05-13 | Rituximab | N | N | 240000663 | RITUXIMAB |
| 240012854 | 240005562 | 1.72 | 91.1 | Disease modification (D) | null | 2016-08-22 | Rituximab | N | N | 240000664 | RITUXIMAB |
| 240012855 | 240005564 | 1.5 | null | Disease modification (D) | 2016-05-12 | 2016-05-12 | Rituximab (INTRAVENOUS Maintenance) | 2 | N | 240000671 | RITUXIMAB |
| 240012856 | 240011044 | 1.75 | 84.3 | Curative (C) | 2016-08-17 | 2018-02-28 | Rituximab | N | N | 240000679 | RITUXIMAB |
| 240012857 | 240005567 | null | 76 | Adjuvant (A) | 2018-08-01 | 2018-08-07 | Rituximab (Maintenance) | 2 | N | 240000683 | RITUXIMAB |
| 240012858 | 240005571 | 1.61 | 59.1 | Adjuvant (A) | 2017-09-25 | 2018-02-20 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 240000689 | RITUXIMAB |
| 240012859 | 240011048 | 1.68 | null | Curative (C) | 2017-07-17 | 2017-07-21 | Rituximab | 02 | N | 240000701 | RITUXIMAB |
| 240012860 | 240005574 | 1.55 | 94.5 | Not known (9) | 2016-05-04 | 2016-05-05 | Rituximab | 02 | null | 240000705 | RITUXIMAB |
| 240012861 | 240016020 | 1.72 | 113 | Adjuvant (A) | null | 2017-08-29 | Rituximab | N | N | 240000739 | RITUXIMAB |
| 240012862 | 240005576 | 1.67 | 70 | Curative (C) | 2018-05-26 | 2018-07-09 | Rituximab | 02 | N | 240000742 | RITUXIMAB |